Myomo, Inc. (MYO)

USD 4.88

(2.95%)

Revenue Summary of Myomo, Inc.

  • Myomo, Inc.'s latest annual revenue in 2023 was 19.24 Million USD , up 23.7% from previous year.
  • Myomo, Inc.'s latest quarterly revenue in 2024 Q2 was 7.52 Million USD , up 100.32% from previous quarter.
  • Myomo, Inc. reported a annual revenue of 15.55 Million USD in annual revenue 2022, up 12.26% from previous year.
  • Myomo, Inc. reported a annual revenue of 13.85 Million USD in annual revenue 2021, up 82.72% from previous year.
  • Myomo, Inc. reported a quarterly revenue of 7.52 Million USD for 2024 Q2, up 100.32% from previous quarter.
  • Myomo, Inc. reported a quarterly revenue of 19.24 Million USD for 2023 FY, up 23.7% from previous quarter.

Annual Revenue Chart of Myomo, Inc. (2023 - 2014)

Historical Annual Revenue of Myomo, Inc. (2023 - 2014)

Year Revenue Revenue Growth
2023 19.24 Million USD 23.7%
2022 15.55 Million USD 12.26%
2021 13.85 Million USD 82.72%
2020 7.58 Million USD 97.6%
2019 3.83 Million USD 57.02%
2018 2.44 Million USD 56.79%
2017 1.55 Million USD 41.29%
2016 1.1 Million USD 59.97%
2015 689.67 Thousand USD -24.48%
2014 913.25 Thousand USD 0.0%

Peer Revenue Comparison of Myomo, Inc.

Name Revenue Revenue Difference
Abbott Laboratories 40.1 Billion USD 99.952%
Allurion Technologies Inc. 53.46 Million USD 64.013%
Artivion, Inc. 354 Million USD 94.565%
Avanos Medical, Inc. 673.3 Million USD 97.142%
Butterfly Network, Inc. 65.9 Million USD 70.802%
Butterfly Network, Inc. 65.9 Million USD 70.802%
Bio-Rad Laboratories, Inc. 2.67 Billion USD 99.28%
Boston Scientific Corporation 14.24 Billion USD 99.865%
CONMED Corporation 1.24 Billion USD 98.449%
Edwards Lifesciences Corporation 6 Billion USD 99.68%
Paragon 28, Inc. 216.38 Million USD 91.108%
Glaukos Corporation 314.71 Million USD 93.886%
Globus Medical, Inc. 1.56 Billion USD 98.773%
Inspire Medical Systems, Inc. 624.79 Million USD 96.92%
Integer Holdings Corporation 1.59 Billion USD 98.795%
Medtronic plc 32.36 Billion USD 99.941%
Nevro Corp. 425.17 Million USD 95.475%
Owlet, Inc. 54.01 Million USD 64.375%
Penumbra, Inc. 1.05 Billion USD 98.182%
Vicarious Surgical Inc. - USD -Infinity%
Smith & Nephew plc 5.54 Billion USD 99.653%
STERIS plc 5.13 Billion USD 99.626%
Stryker Corporation 20.49 Billion USD 99.906%
Vapotherm, Inc. 68.66 Million USD 71.98%
Zimmer Biomet Holdings, Inc. 7.39 Billion USD 99.74%